查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
皮内注射器的全球市场的考察，预测(～2029年)
市场调查报告书
商品编码
1373460

皮内注射器的全球市场的考察，预测(～2029年)

Global Intradermal Injection Device Market Insights, Forecast to 2029
出版日期: | 出版商: QYResearch | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球皮内注射器的市场规模在2023年前将达到1亿910万美元，2029年前预计将成长到1亿3,775万美元，预测期间年复合成长率3.96％的速度成长。

美国·加拿大市场在2023年达到1,979万美元，2029年前预计将成长到2,409万美元，2023年～2029年的预测期间的年复合成长率是3.33％。

中国市场在2023年达到1,564万美元，2029年前预计将成长到2,351万美元，预测期间的年复合成长率是7.03％。

欧洲市场在2023年达到2,282万美元，2029年前预计将成长到2,816万美元，预测期间的年复合成长率是3.56％。

本报告提供全球皮内注射器市场相关调查分析，提供各地区市场规模与预测，市场动态，竞争情形等资讯。

目录

第1章 调查范围

  • 皮内注射器产品的简介
  • 市场:各类型
    • 全球皮内注射器的市场规模成长率:各类型(2018年·2022年·2029年)
    • 抛弃式
    • 可重复使用
  • 市场:各用途
    • 全球皮内注射器的市场规模成长率:各用途(2018年·2022年·2029年)
    • 疫苗
    • 医学的检验
    • 其他
  • 前提条件与限制
  • 调查目的
  • 调查涵盖年数

第2章 摘要整理

  • 全球皮内注射器的收益的估计与预测(2018年～2029年)
  • 全球皮内注射器的收益:各地区
    • 全球皮内注射器的收益:各地区(2018年·2022年·2029年)
    • 全球皮内注射器的收益:各地区(2018年～2023年)
    • 全球皮内注射器的收益:各地区(2024年～2029年)
    • 全球皮内注射器的收益的市场占有率:各地区(2018年～2029年)
  • 全球皮内注射器的销售额的估计与预测(2018年～2029年)
  • 全球皮内注射器的销售额:各地区
    • 全球皮内注射器的销售额:各地区(2018年·2022年·2029年)
    • 全球皮内注射器的销售额:各地区(2018年～2023年)
    • 全球皮内注射器的销售额:各地区(2024年～2029年)
    • 全球皮内注射器的销售额的市场占有率:各地区(2018年～2029年)
  • 美国·加拿大
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第3章 竞争:各製造厂商

  • 全球皮内注射器的销售额:各製造厂商
    • 全球皮内注射器的销售额:各製造厂商(2018年～2023年)
    • 全球皮内注射器的销售额的市场占有率:各製造厂商(2018年～2023年)
    • 全球皮内注射器的3大·5大厂商(2022年)
  • 全球皮内注射器的收益:各製造厂商
    • 全球皮内注射器的收益:各製造厂商(2018年～2023年)
    • 全球皮内注射器的收益的市场占有率:各製造厂商(2018年～2023年)
    • 全球皮内注射器的收益的3大·5大厂商(2022年)
  • 全球皮内注射器的主要企业，产业排行榜(2021年·2022年)
  • 全球皮内注射器的销售价格:各製造厂商(2018年～2023年)
  • 竞争情形的分析
    • 製造商市场集中度(CR5和HHI)
    • 全球皮内注射器的市场占有率:各类型企业(Tier 1·Tier 2·Tier 3)
  • 全球皮内注射器的主要製造商，製造地的分布，总公司
  • 全球皮内注射器的主要製造商，提供产品，用途
  • 全球皮内注射器的主要製造商，产业进入日
  • 合併和收购，扩张计划

第4章 市场规模:各类型

  • 全球皮内注射器的销售额:各类型
    • 全球皮内注射器的销售额的实际成果:各类型(2018年～2023年)
    • 全球皮内注射器的销售额的预测:各类型(2024年～2029年)
    • 全球皮内注射器的销售额的市场占有率:各类型(2018年～2029年)
  • 全球皮内注射器的收益:各类型
    • 全球皮内注射器的收益的实际成果:各类型(2018年～2023年)
    • 全球皮内注射器的收益的预测:各类型(2024年～2029年)
    • 全球皮内注射器的收益的市场占有率:各类型(2018年～2029年)
  • 全球皮内注射器的价格:各类型
    • 全球皮内注射器的价格:各类型(2018年～2023年)
    • 全球皮内注射器的价格的预测:各类型(2024年～2029年)

第5章 市场规模:各用途

  • 全球皮内注射器的销售额:各用途
    • 全球皮内注射器的销售额的实际成果:各用途(2018年～2023年)
    • 全球皮内注射器的销售额的预测:各用途(2024年～2029年)
    • 全球皮内注射器的销售额的市场占有率:各用途(2018年～2029年)
  • 全球皮内注射器的收益:各用途
    • 全球皮内注射器的收益的实际成果:各用途(2018年～2023年)
    • 全球皮内注射器的收益的预测:各用途(2024年～2029年)
    • 全球皮内注射器的收益的市场占有率:各用途(2018年～2029年)
  • 全球皮内注射器的价格:各用途
    • 全球皮内注射器的价格:各用途(2018年～2023年)
    • 全球皮内注射器的价格的预测:各用途(2024年～2029年)

第6章 美国·加拿大

  • 美国·加拿大的皮内注射器的市场规模:各类型
    • 美国·加拿大的皮内注射器的销售额:各类型(2018年～2029年)
    • 美国·加拿大的皮内注射器的收益:各类型(2018年～2029年)
  • 美国·加拿大的皮内注射器的市场规模:各用途
    • 美国·加拿大的皮内注射器的销售额:各用途(2018年～2029年)
    • 美国·加拿大的皮内注射器的收益:各用途(2018年～2029年)
  • 美国·加拿大的皮内注射器的市场规模:各国
    • 美国·加拿大的皮内注射器的收益:各国(2018年·2022年·2029年)
    • 美国·加拿大的皮内注射器的收益:各国(2018年～2029年)
    • 美国·加拿大的皮内注射器的销售额:各国(2018年～2029年)
    • 美国
    • 加拿大

第7章 欧洲

  • 欧洲的皮内注射器的市场规模:各类型
    • 欧洲的皮内注射器的销售额:各类型(2018年～2029年)
    • 欧洲的皮内注射器的收益:各类型(2018年～2029年)
  • 欧洲的皮内注射器的市场规模:各用途
    • 欧洲的皮内注射器的销售额:各用途(2018年～2029年)
    • 欧洲的皮内注射器的销售额:各用途(2018年～2029年)
  • 欧洲的皮内注射器的市场规模:各国
    • 欧洲的皮内注射器的收益:各国(2018年·2022年·2029年)
    • 欧洲的皮内注射器的收益:各国(2018年～2029年)
    • 欧洲的皮内注射器的销售额:各国(2018年～2029年)
    • 德国
    • 法国
    • 英国
    • 义大利
    • 俄罗斯

第8章 亚太地区

  • 亚太地区的皮内注射器的市场规模:各类型
    • 亚太地区的皮内注射器的销售额:各类型(2018年～2029年)
    • 亚太地区的皮内注射器的收益:各类型(2018年～2029年)
  • 亚太地区的皮内注射器的市场规模:各用途
    • 亚太地区的皮内注射器的销售额:各用途(2018年～2029年)
    • 亚太地区的皮内注射器的收益:各用途(2018年～2029年)
  • 亚太地区的皮内注射器的市场规模:各地区
    • 亚太地区的皮内注射器的收益(2018年·2022年·2029年)
    • 亚太地区的皮内注射器的收益:各地区(2018年～2029年)
    • 亚太地区的皮内注射器的销售额:各地区(2018年～2029年)
    • 中国
    • 日本
    • 韩国
    • 印度
    • 亚太地区

第9章 南美

  • 南美的皮内注射器的市场规模:各类型
    • 南美的皮内注射器的销售额:各类型(2018年～2029年)
    • 南美的皮内注射器的收益:各类型(2018年～2029年)
  • 南美的皮内注射器的市场规模:各用途
    • 南美的皮内注射器的销售额:各用途(2018年～2029年)
    • 南美的皮内注射器的收益:各用途(2018年～2029年)
  • 南美的皮内注射器的市场规模:各地区
    • 南美的皮内注射器的收益:各地区(2018年·2022年·2029年)
    • 南美的皮内注射器的收益:各国(2018年～2029年)
    • 南美的皮内注射器的销售额:各国(2018年～2029年)
    • 墨西哥
    • 巴西

第10章 中东·非洲

  • 中东·非洲的皮内注射器的市场规模:各类型
    • 中东·非洲的皮内注射器的销售额:各类型(2018年～2029年)
    • 中东·非洲的皮内注射器的收益:各类型(2018年～2029年)
  • 中东·非洲的皮内注射器的市场规模:各用途
    • 中东·非洲的皮内注射器的销售额:各用途(2018年～2029年)
    • 中东·非洲的皮内注射器的收益:各用途(2018年～2029年)
  • 中东·非洲的皮内注射器的市场规模:各地区
    • 中东·非洲的皮内注射器的收益:各地区(2018年·2022年·2029年)
    • 中东·非洲的皮内注射器的收益:各国(2018年～2029年)
    • 中东·非洲的皮内注射器的销售额:各国(2018年～2029年)
    • 中东
    • 非洲

第11章 企业简介

  • BD
  • Terumo
  • HIPRA
  • NanoPass Technologies
  • Novosanis (Idevax)
  • Idevax
  • PharmaJet
  • Debiotech
  • Lightnix Inc

第12章 产业链和销售管道的分析

  • 皮内注射器的产业链分析
  • 皮内注射器主要的原料
    • 主要的原料
    • 原料的主要供应商
  • 皮内注射器的生产方式和流程
  • 皮内注射器的销售与行销
    • 皮内注射器的销售商
  • 皮内注射器客户

第13章 皮内注射器的市场动态

    • 皮内注射器产业趋势
    • 皮内注射器市场促进因素
    • 皮内注射器市场课题
    • 皮内注射器市场阻碍因素

第14章 全球皮内注射器研究主要的发现

第15章 附录

The global Intradermal Injection Device market is projected to grow from US$ 109.10 million in 2023 to US$ 137.75 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.96% during the forecast period.

The US & Canada market for Intradermal Injection Device is estimated to increase from $ 19.79 million in 2023 to reach $ 24.09 million by 2029, at a CAGR of 3.33% during the forecast period of 2023 through 2029.

The China market for Intradermal Injection Device is estimated to increase from $ 15.64 million in 2023 to reach $ 23.51 million by 2029, at a CAGR of 7.03% during the forecast period of 2023 through 2029.

The Europe market for Intradermal Injection Device is estimated to increase from $ 22.82 million in 2023 to reach $ 28.16 million by 2029, at a CAGR of 3.56% during the forecast period of 2023 through 2029.

The global key manufacturers of Intradermal Injection Device include: Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc. In 2022, the global top five players had a share approximately 84.02% in terms of revenue.

Report Includes:

This report presents an overview of global market for Intradermal Injection Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Intradermal Injection Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intradermal Injection Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intradermal Injection Device sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Intradermal Injection Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Intradermal Injection Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc.

By Company

  • Terumo
  • BD
  • NanoPass Technologies
  • Idevax
  • Debiotech
  • PharmaJet
  • Debiotech
  • Novosanis
  • HIPRA
  • Lightnix Inc

Segment by Type

  • Disposable
  • Reusable

Segment by Application

  • Vaccine
  • Medical Test
  • Others

Segment by Region

  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Intradermal Injection Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Intradermal Injection Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intradermal Injection Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

  • 1.1 Intradermal Injection Device Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Disposable
    • 1.2.3 Reusable
  • 1.3 Market by Application
    • 1.3.1 Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Vaccine
    • 1.3.3 Medical Test
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Intradermal Injection Device Revenue Estimates and Forecasts 2018-2029
  • 2.2 Global Intradermal Injection Device Revenue by Region
    • 2.2.1 Global Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Intradermal Injection Device Revenue by Region (2018-2023)
    • 2.2.3 Global Intradermal Injection Device Revenue by Region (2024-2029)
    • 2.2.4 Global Intradermal Injection Device Revenue Market Share by Region (2018-2029)
  • 2.3 Global Intradermal Injection Device Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Intradermal Injection Device Sales by Region
    • 2.4.1 Global Intradermal Injection Device Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Intradermal Injection Device Sales by Region (2018-2023)
    • 2.4.3 Global Intradermal Injection Device Sales by Region (2024-2029)
    • 2.4.4 Global Intradermal Injection Device Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 Asia-Pacific
  • 2.8 Latin America
  • 2.9 Middle East & Africa

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Intradermal Injection Device Sales by Manufacturers
    • 3.1.1 Global Intradermal Injection Device Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Intradermal Injection Device Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Intradermal Injection Device in 2022
  • 3.2 Global Intradermal Injection Device Revenue by Manufacturers
    • 3.2.1 Global Intradermal Injection Device Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Intradermal Injection Device Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 3 and Top 5 Companies by Intradermal Injection Device Revenue in 2022
  • 3.3 Global Key Players of Intradermal Injection Device, Industry Ranking, 2021 VS 2022
  • 3.4 Global Intradermal Injection Device Sales Price by Manufacturers (2018-2023)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Intradermal Injection Device, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Intradermal Injection Device, Product Offered and Application
  • 3.8 Global Key Manufacturers of Intradermal Injection Device, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Intradermal Injection Device Sales by Type
    • 4.1.1 Global Intradermal Injection Device Historical Sales by Type (2018-2023)
    • 4.1.2 Global Intradermal Injection Device Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • 4.2 Global Intradermal Injection Device Revenue by Type
    • 4.2.1 Global Intradermal Injection Device Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Intradermal Injection Device Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • 4.3 Global Intradermal Injection Device Price by Type
    • 4.3.1 Global Intradermal Injection Device Price by Type (2018-2023)
    • 4.3.2 Global Intradermal Injection Device Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Intradermal Injection Device Sales by Application
    • 5.1.1 Global Intradermal Injection Device Historical Sales by Application (2018-2023)
    • 5.1.2 Global Intradermal Injection Device Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • 5.2 Global Intradermal Injection Device Revenue by Application
    • 5.2.1 Global Intradermal Injection Device Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Intradermal Injection Device Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • 5.3 Global Intradermal Injection Device Price by Application
    • 5.3.1 Global Intradermal Injection Device Price by Application (2018-2023)
    • 5.3.2 Global Intradermal Injection Device Price Forecast by Application (2024-2029)

6 US & CANADA

  • 6.1 US & Canada Intradermal Injection Device Market Size by Type
    • 6.1.1 US & Canada Intradermal Injection Device Sales by Type (2018-2029)
    • 6.1.2 US & Canada Intradermal Injection Device Revenue by Type (2018-2029)
  • 6.2 US & Canada Intradermal Injection Device Market Size by Application
    • 6.2.1 US & Canada Intradermal Injection Device Sales by Application (2018-2029)
    • 6.2.2 US & Canada Intradermal Injection Device Revenue by Application (2018-2029)
  • 6.3 US & Canada Intradermal Injection Device Market Size by Country
    • 6.3.1 US & Canada Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Intradermal Injection Device Revenue by Country (2018-2029)
    • 6.3.3 US & Canada Intradermal Injection Device Sales by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 EUROPE

  • 7.1 Europe Intradermal Injection Device Market Size by Type
    • 7.1.1 Europe Intradermal Injection Device Sales by Type (2018-2029)
    • 7.1.2 Europe Intradermal Injection Device Revenue by Type (2018-2029)
  • 7.2 Europe Intradermal Injection Device Market Size by Application
    • 7.2.1 Europe Intradermal Injection Device Sales by Application (2018-2029)
    • 7.2.2 Europe Intradermal Injection Device Revenue by Application (2018-2029)
  • 7.3 Europe Intradermal Injection Device Market Size by Country
    • 7.3.1 Europe Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Intradermal Injection Device Revenue by Country (2018-2029)
    • 7.3.3 Europe Intradermal Injection Device Sales by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Intradermal Injection Device Market Size by Type
    • 8.1.1 Asia-Pacific Intradermal Injection Device Sales by Type (2018-2029)
    • 8.1.2 Asia-Pacific Intradermal Injection Device Revenue by Type (2018-2029)
  • 8.2 Asia-Pacific Intradermal Injection Device Market Size by Application
    • 8.2.1 Asia-Pacific Intradermal Injection Device Sales by Application (2018-2029)
    • 8.2.2 Asia-Pacific Intradermal Injection Device Revenue by Application (2018-2029)
  • 8.3 Asia-Pacific Intradermal Injection Device Market Size by Region
    • 8.3.1 Asia-Pacific Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 8.3.2 Asia-Pacific Intradermal Injection Device Revenue by Region (2018-2029)
    • 8.3.3 Asia-Pacific Intradermal Injection Device Sales by Region (2018-2029)
    • 8.3.4 China
    • 8.3.5 Japan
    • 8.3.6 South Korea
    • 8.3.7 India
    • 8.3.8 Southeast Asia-Pacific

9 LATIN AMERICA

  • 9.1 Latin America Intradermal Injection Device Market Size by Type
    • 9.1.1 Latin America Intradermal Injection Device Sales by Type (2018-2029)
    • 9.1.2 Latin America Intradermal Injection Device Revenue by Type (2018-2029)
  • 9.2 Latin America Intradermal Injection Device Market Size by Application
    • 9.2.1 Latin America Intradermal Injection Device Sales by Application (2018-2029)
    • 9.2.2 Latin America Intradermal Injection Device Revenue by Application (2018-2029)
  • 9.3 Latin America Intradermal Injection Device Market Size by Region
    • 9.3.1 Latin America Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Latin America Intradermal Injection Device Revenue by Country (2018-2029)
    • 9.3.3 Latin America Intradermal Injection Device Sales by Country (2018-2029)
    • 9.3.4 Mexico
    • 9.3.5 Brazil

10 MIDDLE EAST AND AFRICA

  • 10.1 Middle East and Africa Intradermal Injection Device Market Size by Type
    • 10.1.1 Middle East and Africa Intradermal Injection Device Sales by Type (2018-2029)
    • 10.1.2 Middle East and Africa Intradermal Injection Device Revenue by Type (2018-2029)
  • 10.2 Middle East and Africa Intradermal Injection Device Market Size by Application
    • 10.2.1 Middle East and Africa Intradermal Injection Device Sales by Application (2018-2029)
    • 10.2.2 Middle East and Africa Intradermal Injection Device Revenue by Application (2018-2029)
  • 10.3 Middle East and Africa Intradermal Injection Device Market Size by Region
    • 10.3.1 Middle East and Africa Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East and Africa Intradermal Injection Device Revenue by Country (2018-2029)
    • 10.3.3 Middle East and Africa Intradermal Injection Device Sales by Country (2018-2029)
    • 10.3.4 Middle East
    • 10.3.5 Africa

11 CORPORATE PROFILE

  • 11.1 BD
    • 11.1.1 BD Company Information
    • 11.1.2 BD Overview
    • 11.1.3 BD Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 BD Recent Developments
  • 11.2 Terumo
    • 11.2.1 Terumo Company Information
    • 11.2.2 Terumo Overview
    • 11.2.3 Terumo Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Terumo Recent Developments
  • 11.3 HIPRA
    • 11.3.1 HIPRA Company Information
    • 11.3.2 HIPRA Overview
    • 11.3.3 HIPRA Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 HIPRA Recent Developments
  • 11.4 NanoPass Technologies
    • 11.4.1 NanoPass Technologies Company Information
    • 11.4.2 NanoPass Technologies Overview
    • 11.4.3 NanoPass Technologies Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 NanoPass Technologies Recent Developments
  • 11.5 Novosanis (Idevax)
    • 11.5.1 Novosanis (Idevax) Company Information
    • 11.5.2 Novosanis (Idevax) Overview
    • 11.5.3 Novosanis (Idevax) Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Novosanis (Idevax) Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novosanis (Idevax) Recent Developments
  • 11.6 Idevax
    • 11.6.1 Idevax Company Information
    • 11.6.2 Idevax Overview
    • 11.6.3 Idevax Recent Developments
  • 11.7 PharmaJet
    • 11.7.1 PharmaJet Company Information
    • 11.7.2 PharmaJet Overview
    • 11.7.3 PharmaJet Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 PharmaJet Recent Developments
  • 11.8 Debiotech
    • 11.8.1 Debiotech Company Information
    • 11.8.2 Debiotech Overview
    • 11.8.3 Debiotech Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Debiotech Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9 Lightnix Inc
    • 11.9.1 Lightnix Inc Company Information
    • 11.9.2 Lightnix Inc Overview
    • 11.9.3 Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Intradermal Injection Device Industry Chain Analysis
  • 12.2 Intradermal Injection Device Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Intradermal Injection Device Production Mode & Process
  • 12.4 Intradermal Injection Device Sales and Marketing
    • 12.4.1 Intradermal Injection Device Distributors
  • 12.5 Intradermal Injection Device Customers

13 INTRADERMAL INJECTION DEVICE MARKET DYNAMICS

    • 13.1.1 Intradermal Injection Device Industry Trends
    • 13.1.2 Intradermal Injection Device Market Drivers
    • 13.1.3 Intradermal Injection Device Market Challenges
    • 13.1.4 Intradermal Injection Device Market Restraints

14 KEY FINDINGS IN THE GLOBAL INTRADERMAL INJECTION DEVICE STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

  • Table 1. Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Reusable
  • Table 3. Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 6. Global Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 7. Global Intradermal Injection Device Revenue Market Share by Region (2018-2023)
  • Table 8. Global Intradermal Injection Device Revenue Market Share by Region (2024-2029)
  • Table 9. Global Intradermal Injection Device Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (K Units)
  • Table 10. Global Intradermal Injection Device Sales by Region (2018-2023) & (K Units)
  • Table 11. Global Intradermal Injection Device Sales by Region (2024-2029) & (K Units)
  • Table 12. Global Intradermal Injection Device Sales Market Share by Region (2018-2023)
  • Table 13. Global Intradermal Injection Device Sales Market Share by Region (2024-2029)
  • Table 14. Global Intradermal Injection Device Sales by Manufacturers (2018-2023) & (K Units)
  • Table 15. Global Intradermal Injection Device Sales Share by Manufacturers (2018-2023)
  • Table 16. Global Intradermal Injection Device Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 17. Global Intradermal Injection Device Revenue Market Share by Manufacturers (2018-2023)
  • Table 18. Global Key Players of Intradermal Injection Device, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 19. Intradermal Injection Device Price by Manufacturers (2018-2023) & (US$/K Units)
  • Table 20. Global Intradermal Injection Device Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Intradermal Injection Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intradermal Injection Device as of 2022)
  • Table 22. Global Key Manufacturers of Intradermal Injection Device, Manufacturing Base Distribution and Headquarters
  • Table 23. Global Key Manufacturers of Intradermal Injection Device, Product Offered and Application
  • Table 24. Global Key Manufacturers of Intradermal Injection Device, Date of Enter into This Industry
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 27. Global Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 28. Global Intradermal Injection Device Sales Share by Type (2018-2023)
  • Table 29. Global Intradermal Injection Device Sales Share by Type (2024-2029)
  • Table 30. Global Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 31. Global Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 32. Global Intradermal Injection Device Revenue Share by Type (2018-2023)
  • Table 33. Global Intradermal Injection Device Revenue Share by Type (2024-2029)
  • Table 34. Intradermal Injection Device Price by Type (2018-2023) & (US$/K Units)
  • Table 35. Global Intradermal Injection Device Price Forecast by Type (2024-2029) & (US$/K Units)
  • Table 36. Global Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 37. Global Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 38. Global Intradermal Injection Device Sales Share by Application (2018-2023)
  • Table 39. Global Intradermal Injection Device Sales Share by Application (2024-2029)
  • Table 40. Global Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 41. Global Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 42. Global Intradermal Injection Device Revenue Share by Application (2018-2023)
  • Table 43. Global Intradermal Injection Device Revenue Share by Application (2024-2029)
  • Table 44. Intradermal Injection Device Price by Application (2018-2023) & (US$/K Units)
  • Table 45. Global Intradermal Injection Device Price Forecast by Application (2024-2029) & (US$/K Units)
  • Table 46. US & Canada Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 47. US & Canada Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 48. US & Canada Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 49. US & Canada Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 50. US & Canada Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 51. US & Canada Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 52. US & Canada Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 53. US & Canada Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 54. US & Canada Intradermal Injection Device Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 55. US & Canada Intradermal Injection Device Revenue by Country (2018-2023) & (US$ Million)
  • Table 56. US & Canada Intradermal Injection Device Revenue by Country (2024-2029) & (US$ Million)
  • Table 57. US & Canada Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 58. US & Canada Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 59. Europe Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 60. Europe Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 61. Europe Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 62. Europe Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 63. Europe Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 64. Europe Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 65. Europe Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 66. Europe Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 67. Europe Intradermal Injection Device Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 68. Europe Intradermal Injection Device Revenue by Country (2018-2023) & (US$ Million)
  • Table 69. Europe Intradermal Injection Device Revenue by Country (2024-2029) & (US$ Million)
  • Table 70. Europe Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 71. Europe Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 72. Asia-Pacific Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 73. Asia-Pacific Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 74. Asia-Pacific Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 75. Asia-Pacific Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 76. Asia-Pacific Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 77. Asia-Pacific Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 78. Asia-Pacific Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 79. Asia-Pacific Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 80. Asia-Pacific Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 81. Asia-Pacific Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 82. Asia-Pacific Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 83. Asia-Pacific Intradermal Injection Device Sales by Region (2018-2023) & (K Units)
  • Table 84. Asia-Pacific Intradermal Injection Device Sales by Region (2024-2029) & (K Units)
  • Table 85. Latin America Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 86. Latin America Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 87. Latin America Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 88. Latin America Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 89. Latin America Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 90. Latin America Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 91. Latin America Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 92. Latin America Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 93. Latin America Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 94. Latin America Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 95. Latin America Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 96. Latin America Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 97. Latin America Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 98. Middle East and Africa Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 99. Middle East and Africa Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 100. Middle East and Africa Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 101. Middle East and Africa Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 102. Middle East and Africa Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 103. Middle East and Africa Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 104. Middle East and Africa Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 105. Middle East and Africa Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 106. Middle East and Africa Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 107. Middle East and Africa Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 108. Middle East and Africa Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 109. Middle East and Africa Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 110. Middle East and Africa Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 111. BD Company Information
  • Table 112. BD Description and Major Businesses
  • Table 113. BD Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 114. BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. BD Recent Developments
  • Table 116. Terumo Company Information
  • Table 117. Terumo Description and Major Businesses
  • Table 118. Terumo Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 119. Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Terumo Recent Developments
  • Table 121. HIPRA Company Information
  • Table 122. HIPRA Description and Major Businesses
  • Table 123. HIPRA Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 124. HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. HIPRA Recent Developments
  • Table 126. NanoPass Technologies Company Information
  • Table 127. NanoPass Technologies Description and Major Businesses
  • Table 128. NanoPass Technologies Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 129. NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. NanoPass Technologies Recent Developments
  • Table 131. Novosanis Company Information
  • Table 132. Novosanis (Idevax) Description and Major Businesses
  • Table 133. Novosanis (Idevax) Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 134. Novosanis (Idevax) Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Novosanis (Idevax) Recent Developments
  • Table 136. Idevax Company Information
  • Table 137. Idevax Description and Major Businesses
  • Table 138. Idevax Recent Developments
  • Table 139. PharmaJet Company Information
  • Table 140. PharmaJet Description and Major Businesses
  • Table 141. PharmaJet Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 142. PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. PharmaJet Recent Developments
  • Table 144. Debiotech Company Information
  • Table 145. Debiotech Description and Major Businesses
  • Table 146. Debiotech Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 147. Debiotech Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. Lightnix Inc Company Information
  • Table 149. Lightnix Inc Description and Major Businesses
  • Table 150. Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Key Raw Materials Lists
  • Table 152. Raw Materials Key Suppliers Lists
  • Table 153. Intradermal Injection Device Distributors List
  • Table 154. Intradermal Injection Device Customers List
  • Table 155. Intradermal Injection Device Market Trends
  • Table 156. Intradermal Injection Device Market Drivers
  • Table 157. Intradermal Injection Device Market Challenges
  • Table 158. Intradermal Injection Device Market Restraints
  • Table 159. Research Programs/Design for This Report
  • Table 160. Key Data Information from Secondary Sources
  • Table 161. Key Data Information from Primary Sources
  • Table 162. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Intradermal Injection Device Product Picture
  • Figure 2. Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Intradermal Injection Device Market Share by Type: 2022 & 2029
  • Figure 4. Disposable Product Picture
  • Figure 5. Major Manufacturers of Disposable
  • Figure 6. Reusable Product Picture
  • Figure 7. Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Intradermal Injection Device Market Share by Application: 2022 & 2029
  • Figure 9. Vaccine
  • Figure 10. Medical Test
  • Figure 11. Intradermal Injection Device Report Years Considered
  • Figure 12. Global Intradermal Injection Device Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Intradermal Injection Device Revenue 2018-2029 (US$ Million)
  • Figure 14. Global Intradermal Injection Device Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 15. Global Intradermal Injection Device Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 16. Global Intradermal Injection Device Revenue Market Share by Region (2018-2029)
  • Figure 17. Global Intradermal Injection Device Sales 2018-2029 (K Units)
  • Figure 18. Global Intradermal Injection Device Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K Units)
  • Figure 19. Global Intradermal Injection Device Sales Market Share by Region (2018-2029)
  • Figure 20. US & Canada Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 21. US & Canada Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. Europe Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 23. Europe Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia-Pacific Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia-Pacific Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Latin America Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 27. Latin America Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Middle East & Africa Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 29. Middle East & Africa Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. The Intradermal Injection Device Market Share of Top 3 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 31. The Top 5 and 10 Largest Manufacturers of Intradermal Injection Device in the World: Market Share by Intradermal Injection Device Revenue in 2022
  • Figure 32. Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 33. Global Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 34. Global Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 35. Global Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 36. Global Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 37. US & Canada Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 38. US & Canada Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 39. US & Canada Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 40. US & Canada Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 41. US & Canada Intradermal Injection Device Revenue Share by Country (2018-2029)
  • Figure 42. US & Canada Intradermal Injection Device Sales Share by Country (2018-2029)
  • Figure 43. US Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 44. Canada Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 45. Europe Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 46. Europe Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 47. Europe Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 48. Europe Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 49. Europe Intradermal Injection Device Revenue Share by Country (2018-2029)
  • Figure 50. Europe Intradermal Injection Device Sales Share by Country (2018-2029)
  • Figure 51. Germany Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 52. France Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 53. U.K. Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 54. Italy Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 55. Russia Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 56. Asia-Pacific Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 57. Asia-Pacific Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 58. Asia-Pacific Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 59. Asia-Pacific Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 60. Asia-Pacific Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 61. Asia-Pacific Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 62. China Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 63. Japan Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 64. South Korea Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 65. India Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 66. Southeast Asia-Pacific Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 67. Latin America Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 68. Latin America Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 69. Latin America Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 70. Latin America Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 71. Latin America Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 72. Latin America Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 73. Mexico Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 74. Brazil Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 75. Middle East and Africa Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 76. Middle East and Africa Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 77. Middle East and Africa Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 78. Middle East and Africa Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 79. Middle East and Africa Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 80. Middle East and Africa Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 81. Middle East Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 82. Africa Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 83. Intradermal Injection Device Value Chain
  • Figure 84. Distributors Profiles
  • Figure 85. Bottom-up and Top-down Approaches for This Report
  • Figure 86. Data Triangulation
  • Figure 87. Key Executives Interviewed